1527-6473/asset/LT_left.gif?v=1&s=e1df7d33719b841a3479d2fd0a24baa5df4653e4)
1527-6473/asset/LT_right.gif?v=1&s=5deda9b4c4c603398e58a7274cf47e5b03ffc5fe)
Liver Transplantation And Hepatitis C: A Single Topic And Consensus Development Symposium
You have full text access to this OnlineOpen article
Host and donor risk factors before and after liver transplantation that impact HCV recurrence
Article first published online: 30 DEC 2003
DOI: 10.1053/jlts.2003.50243
Copyright © 2003 American Association for the Study of Liver Diseases
1527-6473/asset/cover.gif?v=1&s=8c6a04b26832399220fbb731e05bd8cc9ff13ae2 "Liver Transplantation")
Additional Information
How to Cite
Berenguer, M. (2003), Host and donor risk factors before and after liver transplantation that impact HCV recurrence. Liver Transpl, 9: S44–S47. doi: 10.1053/jlts.2003.50243
Publication History
- Issue published online: 30 DEC 2003
- Article first published online: 30 DEC 2003
References
- 1, , , , . The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002; 122:889–896.
- 2, , . Hepatitis C and liver transplantation. J Hepatol 2001; 35:666–678.
- 3, , , , , , et al. Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients. Hepatology 2002; 36:202–210.
- 4. Natural history of recurrent hepatitis C. Liver Transpl 2002; 8(suppl 1):14–18.
- 5, , , , , , et al. Natural history of clinically compensated HCV-related graft cirrhosis after liver transplantation. Hepatology 2000; 32:852–858.
- 6, , , , , , et al. HCV-related fibrosis progression after liver transplantation: Increase in recent years. J Hepatol 2000; 32:673–684.
- 7, , , . Advancing donor liver age and rapid fibrosis progression after transplantation for hepatitis C. Gut 2002; 51:248–252.
- 8, , , , , , et al. Slowly tapering off steroids protects the graft against hepatitis C recurrence after liver transplantation. Liver Transpl 2002; 8:884–888.
- 9
- 10, , , , , , et al. Are post-transplantation protocol liver biopsies useful in the long-term? Liver Transpl 2001; 7:790–796.
- 11, , . Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997; 349:825–832.
- 12, , , , , , et al. Liver transplantation in adults coinfected with HIV. Transplantation 2001; 72:1684–1688.
- 13, , , , , , et al. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection after transplantation: Relationship with rejection episodes. Hepatology 1999; 29:250–256.
- 14, , , , , , et al. Predictors of patient and graft survival after liver transplantation for hepatitis C. Hepatology 1998; 28:823–830.
- 15, , , , , , et al. The effect of anti-interleukin-2 receptor therapy on the course of hepatitis C recurrence after liver transplantation. Liver Transpl 2001; 7:1064–1070.
- 16, , , , , , et al. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation. Am J Gastroenterol 1997; 92:1453–1457.
- 17, , , , , , et al. Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation. Hepatology 1995; 21: 30–34
- 18, , , , , , et al. Early development of chronic active hepatitis in recurrent hepatitis C virus infection after liver transplantation: Association with treatment of rejection. J Hepatol 1998; 28:756–763.
- 19. The role of immunosuppression in recurrence of hepatitis C. Liver Transpl 2003; 9(suppl 3):S63–S66.
- 20, , , , , , . Donor polymorphism of tumor necrosis factor gene. Relationship with variable severity of hepatitis C recurrence after liver transplantation. Transplantation 1999; 68:1898–1902.
- 21, , , , , . The influence of HLA donor-recipient compatibility on the recurrence of HBV and HCV hepatitis after liver transplantation. Transplantation 1994; 59:640–642.
- 22, , , , , , et al. The influence of hepatitis C virus genotypes on the outcome of liver transplantation. Liver Transpl Surg 1998; 4:22–27.
- 23, , , , , , et al. The outcome of liver grafts procured from hepatitis C-positive donors. Transplantation 2002; 73:582–587.
- 24, , . The use of hepatitis C-infected grafts in liver transplantation. Liver Transpl 2003; 9(suppl 3):S48–S51.
- 25, , , , , , . Timing and severity of initial hepatitis C recurrence as predictors of long-term liver allograft injury. Transplantation 1998; 65:1178–1182.
- 26, , , , , , et al. Histology predicts cirrhotic evolution of post transplant hepatitis C. Gut 2002; 50:697–700.
- 27, , , , , , et al. Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantation. Hepatology 2000; 32:1125–1130.
- 28, , , , , , et al. Histologic and clinical outcome after liver transplantation for hepatitis C. Hepatology 1997; 26:1646–1652.
- 29, , , , , , et al. Liver transplantation for hepatitis C: Recurrence and disease progression in 300 patients. Liver Transpl 2000; 6:553–561.
- 30, , , , , , et al. Hepatocellular carcinoma: Can it be considered a controversial indication for liver transplantation in centers with high rates of hepatitis C? Liver Transpl 2002; 8:1020–1027.
- 31, , , , , , et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334:693–699.
- 32, , , , , , et al. European Collaborative Study on factors influencing the outcome after liver transplantation for hepatitis C. Gastroenterology 1999; 117:619–625.
- 33, , , , , , et al. Long-term outcome of hepatitis C virus infection after liver transplantation. Hepatology 1997; 25:203–210.